Myocardial Solutions Welcomes Clete Madden as New CEO

Myocardial Solutions, Inc. Welcomes Clete Madden as Chief Executive Officer

Morrisville, NC – Myocardial Solutions, Inc. (MSI), a leading innovator in cardiac care, is excited to announce the appointment of Clete Madden as its new Chief Executive Officer (CEO), effective May 1, 2024. With this appointment, Bob Kay, the current CEO, will transition to the role of Chairman of the Board and Clete will drive the adaption and growth of MyoStrain.

MyoStrain software rapidly detects subclinical cardiac dysfunction across 48 segments of the heart—before patients are symptomatic. The early detection of dysfunction enables physicians to take a more proactive and preventative approach. In addition, MyoStrain provides visibility into the efficacy of treatment by measuring treatment effects on the heart, which allows physicians to optimize therapies for the individual patient.

Clete Madden brings with him over 30 years of experience in the healthcare industry. Prior to joining MSI, Madden served as the President of Touchstone Medical Imaging, where he played a pivotal role in its significant growth. Under his leadership, Touchstone expanded from 10 to over 60 outpatient imaging centers, establishing joint ventures with esteemed institutions like Baylor Scott & White Health and SCL/Intermountain Healthcare. Notably, Touchstone's growth benefited millions of patients across the nation and revenues grew from $38 million to over $250 million during Madden's tenure.

Following Touchstone's acquisition by US Radiology (USR), a WCAS PE-backed platform, Madden continued to excel as a member of URS’s Executive Committee. He played a crucial role in shaping USR's vision, operating the outpatient business, and spearheading significant development deals, including the acquisition of numerous outpatient centers and a joint venture with INTEGRIS Health.

Madden's career also included Partner and National Healthcare Industry Director at KPMG, Chief Development Officer (CDO) for RadNet, and CEO of Pacesetter Health. His extensive leadership experience and deep understanding of the healthcare landscape position him as a strong asset to MSI.

"We are pleased to welcome Clete Madden as the new CEO of Myocardial Solutions, Inc.," said Bob Kay, outgoing CEO at MSI. "Clete's proven track record of driving growth and innovation in the healthcare sector and outpatient imaging center industry aligns

perfectly with MSI's mission to revolutionize preventive cardiac care. His leadership will be instrumental as we continue to expand our footprint and impact the industry."

Madden joins an esteemed leadership team at MSI, including President and Chief Operating Officer Richard Roberts, Chief Medical Officer and Global Head of Medical Affairs Dr. Rafa Rivero, Chief Clinical Officer Jim Wayne, Founder and Chief Science Officer Nael Osman, and Senior Vice President of Operations Sidney Fleischman. "I am honored and excited to join Myocardial Solutions, Inc. at such an pivotal time in its patient care journey. I believe this technology will provide a significant benefit to global population health while bending the healthcare cost curve," said Madden. "In my personal experience I have seen how MyoStrain benefits patients. I look forward to working closely with the talented team at MSI to drive innovation, expand market reach, and ultimately, improve patient outcomes in cardiac care." About Myocardial Solutions, Inc.: Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, non-invasive heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe. For media inquiries, please contact: Linda Horne 919-459-9102 linda.horne@mycardialsolutions.com

‍